• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Nu.Q vet cancer test now available through IDEXX’s reference laboratory network

January 12, 2023

SAP Partners | <b>Volition Veterinary</b>

Volition follows through on global supply agreement announced in October 2022

Volition, a multinational epigenetics company, announced today the availability of its Nu.Q Vet Cancer Test through the IDEXX reference laboratory network in the US.1

Tom Butera, DVM, Chief Executive Officer of Volition Veterinary Diagnostics Development LLC, said: “IDEXX is a global leader in pet healthcare innovation and well-positioned to roll out the IDEXX Nu.Q Canine Cancer Screen worldwide. It is a simple, cost effective, easy to use blood test for screening older or ‘at risk’ dogs. Our Nucleosomics technology is easy to incorporate into annual wellness visits to support veterinarians in their clinical decision-making, enable earlier detection and treatment of cancer and improve the health and wellbeing of pets and pet owners."

Results from a clinical study at Texas A&M University, peer-reviewed and published in August 2022, showed that Volition’s Nu.Q Vet Cancer Test detected 76% of systemic cancers (including lymphoma, hemangiosarcoma, and histiocytic sarcoma) at 97% specificity versus control.2

Advertisement

“IDEXX’s launch of the Nu.Q Canine Cancer Screen in the US this week, under our previously announced supply agreement, ultimately provides worldwide customer reach through its global reference laboratory network as we continue to commercialize our transformational Nu.Q technology within the companion animal healthcare sector and capitalize on the significant opportunities available,” said Butera.

The Veterinary Cancer Society estimates that 1 in 4 dogs will develop cancer at some point, and almost 50% of dogs over the age of 10 will develop cancer.3 Approximately 6 million new cancer diagnoses are made in dogs in the US each year.4

References

  1. Volition announces expansion of availability of the Nu.Q® Vet Cancer Test through IDEXX’s Reference Laboratory Network. News Release. VolitionRx Limited. January 12, 2023.
  2. Wilson-Robles HM, Bygott T, Kelly TK, et al. Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers and in healthy dogs. BMC Vet Res. 2022;18(1):329. Published 2022 Aug 31. doi:10.1186/s12917-022-03429-8
  3. Frequently asked questions. Veterinary Cancer Society. Accessed January 12, 2023. http://vetcancersociety.org/pet-owners/faqs
  4. What is comparative oncology? National Cancer Institute Center for Research. Accessed January 12, 2023. https://ccr.cancer.gov/Comparative-Oncology-Program/pet-owners/what-is-comp-onc

Related Content:

Volition VeterinaryOncologyProductsAssociates
Brief overview of acid-base interpretation
Brief overview of acid-base interpretation
Communicating the importance of genetic screening
Communicating the importance of genetic screening
Study reveals Zymox Otic Plus is beneficial and effective
Study reveals Zymox Otic Plus is beneficial and effective

Advertisement

Latest News

The Vets appoints Dr Zach Mills to VP of Medical Performance

Communicating the importance of genetic screening

Purina announces its 2023 Pet Care Innovation Prize winners

AmeriVet Veterinary Partners deemed a 2022 Business of the Year

View More Latest News
Advertisement